Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Italy Poland Spain
  • Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria Croatia Czechia Denmark France +11
  • Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Austria Belgium France Germany Portugal Spain
  • Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +2
  • Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    France
  • Study of Mosunetuzumab and Polatuzumab Vedotin Combination Treatment in Patients with B-Cell Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Belgium Spain
  • Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1
    Austria Belgium Czechia Denmark Finland France +10
  • Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland Norway Sweden
  • Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients

    Not recruiting

    2 1 1 1
    Belgium France
  • Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1 1
    France Spain